CD86 and infection: Although the infection rates of SARS-CoV-2 in iMΦ were approximately 11% and 4% for Delta and Omicron, respectively (Fig. 3B), the infection did activate iMΦ to upregulate mRNA expression of the M1 phenotype marker CD86 (Fig. S4; Table S5).